USFDA Issues Import Alert On Glenmark Pharma's Baddi Manufacturing Plant

Glenmark Pharmaceuticals on Wednesday said the US health regulator has put its manufacturing plant at Baddi under import alert

Topics

USFDA | Glenmark Pharmaceuticals

Press Trust of India  |  New Delhi 



Glenmark Pharmaceuticals

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();

on Wednesday said the US health regulator has put its manufacturing plant at Baddi under import alert.

The drugs produced at the Baddi unit can now be detained without physical examination.

The US Food and Drug Administration inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status.

The OAI classification implied that the may withhold approval of any pending product applications or supplements filed from such facility till the outstanding observations related to non-compliance with manufacturing norms laid down by the regulator.

"We now wish to inform you that the US FDA has placed the Baddi (India) facility under import alert 66-40," said in a regulatory filing.

As per the USFDA, import alert 66-40 implies detention without physical examination of drugs from firms which have not met drug GMPs.

"The US revenues from products supplied from this facility contributed to 1-2 per cent of FY22 total revenues for the company," Glenmark said.

In FY22, the company posted revenue of Rs 8,141.58 crore, as per BSE records.

Glenmark said it will engage with the agency to resolve the import alert at the earliest.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

First Published: Wed, October 26 2022. 23:15 IST


RECENT NEWS

Monzo Looks For US Banking License

Monzo is preparing a renewed push to secure a US banking licence, four years after abandoning its first attempt when tal... Read more

Crypto Firms Push Into US Banking

America’s cryptocurrency companies are scrambling to secure a foothold in the country’s traditional banking system, ... Read more

Parallel Banking: Stablecoins Are Now Global

Parallel Banking: How Stablecoins Are Building a New Global Payments SystemStablecoins—digital currencies pegged to tr... Read more

JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity

JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more

Private Equity And Banks: The Complex Web Of Leverage

Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more

Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector

The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more